Menopause Related Conditions
41
6
8
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.9%
2 terminated out of 41 trials
90.0%
+3.5% vs benchmark
12%
5 trials in Phase 3/4
17%
3 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (41)
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Food Trial Evaluating Fecal Abundance of SBD111 With Once-Daily Versus Twice-Daily Administration in Healthy Adults
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.
Estradiol Supplementation and Rotator Cuff Repair
Low-level Laser Therapy in Genitourinary Symptoms of Menopause
Targeting Insomnia to Prevent Depression in the Menopause Transition
Hot Water Therapy for the Treatment of Menopause-related Hot Flashes
Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms
Laser Therapy for Treatment of Urogenital Symptoms in Women
Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause).
Solution-focused Counseling for Menopausal Symptoms
Progressive Relaxation Exercise, Menopausal Symptoms and Working Performance
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
Effects of Beef Consumption on Skeletal Muscle Protein Homeostasis and Inflammatory Factors in Pre- and Postmenopausal Females
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
Menopause Racing Heart Study
Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients
Affect of Duavive on Mood & Anxiety Symptoms
A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial